Embryonic survival and severity of cardiac and craniofacial defects are affected by genetic background in fibroblast growth factor-16 null mice

DNA and Cell Biology

Volumn 29, Issue 8, 2010, Pages 407-415

  Lu, Shun Yan ^a   Jin, Yan ^b   Li, Xiaodong ^c   Sheppard, Patricia ^b   Bock, Margaret E ^b   Sheikh, Farah ^c   Duckworth, Mary Lynn ^b   Cattini, Peter A ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 4; FIBROBLAST GROWTH FACTOR 16; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR 9; NEU DIFFERENTIATION FACTOR; VELAFERMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL HEART MALFORMATION; CRANIOFACIAL MALFORMATION; DISEASE SEVERITY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE MUTATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; CRANIOFACIAL ABNORMALITIES; DNA HELICASES; EMBRYO, MAMMALIAN; FEMALE; FIBROBLAST GROWTH FACTORS; HEART DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR PROTEINS; PHENOTYPE; X CHROMOSOME;

MUS;

EID: 77955885703     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1024     Document Type: Article

References (31)

1. Astrof, S., Kirby, A., Lindblad-Toh, K., Daly, M., and Hynes, R.O. (2007). Heart development in fibronectin-null mice is governed by a genetic modifier on chromosome four. Mech Dev 124, 551-558.
2. Bérubé, N.G., Mangelsdorf, M., Jagla, M., Vanderluit, J., Garrick, D., Gibbons, R.J., Higgs, D.R., Slack, R.S., and Picketts, D.J. (2005). The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. J Clin Invest 115, 258-267.
3. Chapman, S.C., Cai, Q., Bleyl, S.B., and Schoenwolf, G.C. (2006). Restricted expression of Fgf16 within the developing chick inner ear. Dev Dyn 235, 2276-2281.
4. Cohen, E.D., Wang, Z., Lepore, J.J., Lu, M.M., Taketo, M.M., Epstein, D.J., and Morrisey, E.E. (2007). Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. J Clin Invest 117, 1794-1804.
5. Falls, D.L. (2003). Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284, 14-30.
6. Garrick, D., Sharpe, J.A., Arkell, R., Dobbie, L., Smith, A.J., Wood, W.G., Higgs, D.R., and Gibbons, R.J. (2006). Loss of ATRX affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues. PLoS Genet 2, e58.
7. Hao, Z., Duncan, G.S., Chang, C.C., Elia, A., Fang, M., Wakeham, A., Okada, H., Calzascia, T., Jang, Y., You-Ten, A., Yeh, W.C., Ohashi, P., Wang, X., and Mak, T.W. (2005). Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis. Cell 121, 579-591.
8. Hatch, E.P., Urness, L.D., and Mansour, S.L. (2009). Fgf16(IRESCre) mice: a tool to inactivate genes expressed in inner ear cristae and spiral prominence epithelium. Dev Dyn 238, 358-366.
9. Hotta, Y., Sasaki, S., Konishi, M., Kinoshita, H., Kuwahara, K., Nakao, K., and Itoh, N. (2008). Fgf16 is required for cardiomyocyte proliferation in the mouse embryonic heart. Dev Dyn 237, 2947-2954.
10. Itoh, N. (2007). The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease. Biol Pharm Bull 30, 1819-1825.
11. Itoh, N., and Ornitz, D.M. (2004). Evolution of the Fgf and Fgfr gene families. Trends Genet 20, 563-569.
12. Iwamoto, R., and Mekada, E. (2006). ErbB and HB-EGF signaling in heart development and function. Cell Struct Funct 31, 1-14.
13. Kim, H.S., Hidaka, K., and Morisaki, T. (2003). Expression of ErbB receptors in ES cell-derived cardiomyocytes. Biochem Biophys Res Commun 309, 241-246.
14. Kirikoshi, H., Sagara, N., Saitoh, T., Tanaka, K., Sekihara, H., Shiokawa, K., and Katoh, M. (2000). Molecular cloning and characterization of human FGF-20 on chromosome 8p21.3-p22. Biochem Biophys Res Commun 274, 337-343. (Pubitemid 30614320)
15. Krezowski, J., Knudson, D., Ebeling, C., Pitstick, R., Giri, R.K., Schenk, D., Westaway, D., Younkin, L., Younkin, S.G., Ashe, K.H., and Carlson, G.A. (2004). Identification of loci determining susceptibility to the lethal effects of amyloid precursor protein transgene overexpression. Hum Mol Genet 13, 1989-1997.
16. Lavine, K.J., Yu, K., White, A.C., Zhang, X., Smith, C., Partanen, J., and Ornitz, D.M. (2005). Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev Cell 8, 85-95.
17. Linder, C.C. (2006). Genetic variables that influence phenotype. ILAR J 47, 132-140.
18. Lu, S.Y., Sheikh, F., Sheppard, P.C., Fresnoza, A., Duckworth, M.L., Detillieux, K.A., and Cattini, P.A. (2008a). FGF-16 is required for embryonic heart development. Biochem Biophys Res Commun 373, 270-274.
19. Lu, S.Y., Sontag, D.P., Detillieux, K.A., and Cattini, P.A. (2008b). FGF-16 is released from neonatal cardiac myocytes and alters growth-related signaling: a possible role in postnatal development. Am J Physiol Cell Physiol 294, C1242-C1249.
20. Lygate, C.A., Hunyor, I., Medway, D., de Bono, J.P., Dawson, D., Wallis, J., Sebag-Montefiore, L., and Neubauer, S. (2009). Cardiac phenotype of mitochondrial creatine kinase knockout mice is modified on a pure C57BL/6 genetic background. J Mol Cell Cardiol 46, 93-99.
21. Miyake, A., Konishi, M., Martin, F.H., Hernday, N.A., Ozaki, K., Yamamoto, S., Mikami, T., Arakawa, T., and Itoh, N. (1998). Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family. Biochem Biophys Res Commun 243, 148-152. (Pubitemid 28414206)
22. Miyamoto, M., Naruo, K., Seko, C., Matsumoto, S., Kondo, T., and Kurokawa, T. (1993). Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 13, 4251-4259.
23. Nomura, R., Kamei, E., Hotta, Y., Konishi, M., Miyake, A., and Itoh, N. (2006). Fgf16 is essential for pectoral fin bud formation in zebrafish. Biochem Biophys Res Commun 347, 340-346.
24. Ohmachi, S., Watanabe, Y., Mikami, T., Kusu, N., Ibi, T., Akaike, A., and Itoh, N. (2000). FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain. Biochem Biophys Res Commun 277, 355-360.
25. Pentassuglia, L., and Sawyer, D.B. (2009). The role of neuregulin-1beta/ErbB signaling in the heart. Exp Cell Res 315, 627-637.
26. Sebastiani, G., Krzywkowski, P., Dudal, S., Yu, M., Paquette, J., Malo, D., Gervais, F., and Tremblay, P. (2006). Mapping genetic modulators of amyloid plaque deposition in TgCRND8 transgenic mice. Hum Mol Genet 15, 2313-2323.
27. Sofronescu, A.G., Detillieux, K.A., and Cattini, P.A. (2010). FGF-16 is a target for adrenergic stimulation through NF-kB activation in postnatal cardiac cells and adult mouse heart. Cardiovasc Res 87, 102-110.
28. Strunk, K.E., Amann, V., and Threadgill, D.W. (2004). Phenotypic variation resulting from a deficiency of epidermal growth factor receptor in mice is caused by extensive genetic heterogeneity that can be genetically and molecularly partitioned. Genetics 167, 1821-1832.
29. Waldo, K.L., Kumiski, D.H., Wallis, K.T., Stadt, H.A., Hutson, M.R., Platt, D.H., and Kirby, M.L. (2001). Conotruncal myocardium arises from a secondary heart field. Development 128, 3179-3188.
30. Wright, J., Hatch, E.P., Karabagli, H., Karabagli, P., Schoenwolf, G.C., and Mansour, S.L. (2003). Expression of mouse fibroblast growth factor and fibroblast growth factor receptor genes during early inner ear development. Dev Dyn 228, 267-272.
31. Zhao, Y-Y., Sawyer, D.R., Baliga, R.R., Opel, D.J., Han, X., Marchionni, M.A., and Kelly, R.A. (1998). Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 273, 10261-10269.